Emcure Pharmaceuticals IPO Subscription Status and Review
The Emcure Pharmaceuticals IPO has witnessed an overwhelming response from investors. On the third day of bidding, the IPO was oversubscribed with non-institutional investors leading the charge. As per the BSE data at 13:00 IST, the subscription status stood at an impressive 11.63 times. Non-institutional investors subscribed 31.67 times, retail investors booked their portion 5.36…